The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis

Volume: 29, Issue: 3, Pages: 641 - 644
Published: Apr 21, 2021
Abstract
The notion that the use of non-steroidal anti-inflammatory drugs (NSAIDs) may lead to adverse outcomes upon acquisition of coronavirus disease 2019 (COVID-19) should be discredited with a review of the real-life evidence. We aimed to perform a meta-analysis to summarize the risk of mortality with the preadmission/pre-diagnosis use of NSAIDs in patients with COVID-19. A systematic literature search was performed to identify eligible studies in...
Paper Details
Title
The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis
Published Date
Apr 21, 2021
Volume
29
Issue
3
Pages
641 - 644
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.